Skip to content
Close menu
SHOP ALL
Shop by Product
Defend
Wake
Wake
Elevate
Elevate
Active
Recover
Boost
Sleep
Rest
Energize
Energize
Unwind
Unwind
LEARN
About Us
Take the Quiz
Our Mushrooms
Lionโs Mane
Reishi
Shiitake
Cordyceps
Chaga
Library
STOCKISTS
AFFILIATES
Log in
Facebook
Instagram
TikTok
LinkedIn
Your Items
Close cart
๐ BETTER ENERGY โ COGNITION โ MOOD โ IMMUNITY โ SLEEP ๐
"Close"
SHOP ALL
Shop by Product
Defend
Wake
Wake
Elevate
Elevate
Active
Recover
Boost
Sleep
Rest
Energize
Energize
Unwind
Unwind
LEARN
About Us
Take the Quiz
Our Mushrooms
Lionโs Mane
Reishi
Shiitake
Cordyceps
Chaga
Library
STOCKISTS
AFFILIATES
Log in
Search
Site navigation
Cart
Search
"Close (esc)"
investor news.
CSE: MOOD | FSE: VU7 | OTC: DOSEF
investor news
Jan 13, 2022
Doseology Appoints Maryam Marissen as CEO to Prepare for Next Growth Stage
Jan 06, 2022
Doseology Completes Development and Test Marketing of Adaptogenic Mushroom Product Line
Dec 31, 2021
Investor Year End Update
Dec 15, 2021
Doseology Prepares to Expand Mushroom Production by Hiring Dr. Wellman-Labadie to Oversee Planned Research and Development Laboratory
Dec 06, 2021
Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealerโs License Application
Nov 15, 2021
Doseology Set to Trade CSE: MOOD
Nov 12, 2021
Doseology Receives Receipt for Final Prospectus and Amounts Listing on the CSE : MOOD
May 13, 2021
Doseology Raises $4,451,568 and Files Preliminary Non-offering Prospectus.
Previous
1
2
3
"Close (esc)"